439 — Kuangchi Science Income Statement
0.000.00%
- HK$905.07m
- HK$932.75m
- HK$75.51m
Annual income statement for Kuangchi Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 99.5 | 114 | 52.5 | 83.1 | 75.5 |
| Cost of Revenue | |||||
| Gross Profit | 38.6 | 41.7 | 10.8 | 14.7 | 20.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 145 | 157 | 123 | 92.7 | 128 |
| Operating Profit | -45.2 | -43.1 | -70.2 | -9.59 | -52.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -77.2 | -40.6 | -67.9 | -7.29 | -44.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -77.3 | -40.6 | -67.9 | -7.29 | -47.4 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -78.3 | -40.6 | -67.9 | -7.29 | -47.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -78.3 | -40.6 | -67.9 | -7.29 | -47.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.139 | -0.066 | -0.107 | -0.033 | -0.081 |